"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...

It feels fantastic,” said Blau, who thanked her lab members and colleagues for their support and dedication. “This achievement is a reflection of our collective efforts and ...

It demonstrates immense potential in production applications, scientific research, and sustainable development. The utilization of advanced gene editing technologies, such as CRISPR/Cas9, has ...

As an efficient gene editing tool, the CRISPR/Cas9 system ... article reviews the application of CRISPR technology in the study of plant active substances, discussing its potential, the problems that ...

CRISPR-Cas9 is one of the biggest discoveries ... The technology is also significantly impacting the development of crops, foods, and industrial fermentation processes. The one application that has ...

Subject enrolment is anticipated to be completed by the second half of this year and the company aims to submit a biologics license application (BLA) in 2026. The therapy launch in the US market is ...

Her lab, in collaboration with Gaurav Sahay, Ph.D. at Oregon State University, is focusing on the development of lipid nanoparticle ... first Phase 1/2 clinical trial evaluating an in vivo CRISPR/Cas9 ...

the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome ... patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene autotemcel).

These awards went to the biotechnology companies Moderna, which Afeyan co-founded, and Pfizer, for their development of vaccines ... used CRISPR to edit genes in mammalian cells. The CRISPR system ...